Gestational diabetes screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
== | == 2016 American Diabetes Association Standards of Medical Care in Diabetes (DO NOT EDIT)<ref name="pmid26696680">{{cite journal |vauthors= |title=Standards of Medical Care in Diabetes-2016: Summary of Revisions |journal=Diabetes Care |volume=39 Suppl 1 |issue= |pages=S4–5 |year=2016 |pmid=26696680 |doi=10.2337/dc16-S003 |url=}}</ref>== | ||
===Screening for Gestational Diabetes (GDM)=== | ===Screening for Gestational Diabetes (GDM)=== | ||
{|class="wikitable" | {|class="wikitable" | ||
| bgcolor="Seashell"|<nowiki>"</nowiki>'''1.''' | | bgcolor="Seashell"|<nowiki>"</nowiki>'''1.''' Test for undiagnosed type 2 diabetes at the first prenatal visit in those with risk factors, using standard diagnostic criteria ''([[American Diabetes Association#Evidence Grading System|Level of Evidence: B]])''<nowiki>"</nowiki> | ||
|- | |- | ||
| bgcolor="Seashell"|<nowiki>"</nowiki>'''2.''' In pregnant women not previously known to have diabetes, screen for GDM at 24–28 weeks of gestation, using a 75-g 2-h OGTT. ''([[ADA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> | | bgcolor="Seashell"|<nowiki>"</nowiki>'''2.''' In pregnant women not previously known to have diabetes, screen for GDM at 24–28 weeks of gestation, using a 75-g 2-h OGTT. ''([[ADA guidelines classification scheme#Level of Evidence|Level of Evidence: B]])''<nowiki>"</nowiki> |
Revision as of 18:09, 28 November 2016
Gestational diabetes Microchapters |
Complications |
Diagnosis |
Treatment |
Case Studies |
Gestational diabetes screening On the Web |
American Roentgen Ray Society Images of Gestational diabetes screening |
Risk calculators and risk factors for Gestational diabetes screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
2016 American Diabetes Association Standards of Medical Care in Diabetes (DO NOT EDIT)[1]
Screening for Gestational Diabetes (GDM)
"1. Test for undiagnosed type 2 diabetes at the first prenatal visit in those with risk factors, using standard diagnostic criteria (Level of Evidence: B)" |
"2. In pregnant women not previously known to have diabetes, screen for GDM at 24–28 weeks of gestation, using a 75-g 2-h OGTT. (Level of Evidence: B)" |
"3. Screen womenwithGDMfor persistent diabetes at 6–12 weeks postpartum, using the OGTT and nonpregnancy diagnostic criteria. (Level of Evidence: E)" |
"4. Women with a history of GDM should have lifelong screening for the development of diabetes or prediabetes at least every 3 years. (Level of Evidence: B)" |
"4. Women with a history of GDM found to have prediabetes should receive lifestyle interventions or metformin to prevent diabetes. (Level of Evidence: A)" |
References
- ↑ "Standards of Medical Care in Diabetes-2016: Summary of Revisions". Diabetes Care. 39 Suppl 1: S4–5. 2016. doi:10.2337/dc16-S003. PMID 26696680.